Sanofi to produce 100 million Pfizer/BioNTech vaccine doses, CEO says
- Country:
- France
French pharma giant Sanofi will produce more than 100 million doses of the COVID-19 vaccine developed by its competitors Pfizer and BioNTech by the end of the year, CEO Paul Hudson told Le Figaro newspaper in an interview published on Tuesday.
As Sanofi and its British partner GlaxoSmithKline have delayed the launch of their shot to late 2021, the French company decided to approach Pfizer "in order to be helpful as of now", Hudson said, adding that an agreement with the U.S. company had been reached.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
Advertisement
ALSO READ
Mbappé scores a deflected goal as PSG beats Rennes 1-0 to reach French Cup final
EXCLUSIVE-U.S. sanctions hamper Russian efforts to repair refineries, sources say
COLUMN-U.S. manufacturers emerge from slump, set to boost fuel use: Kemp
Nearly 20 years on, 75-year-old man convicted of murder of British police officer during a robbery
Euro zone yields fall after U.S. jobless claims rise